"Designing Growth Strategies is in our DNA"

Particle Therapy Market Size, Share & Industry Analysis, By Type (Proton Therapy, Heavy Ion Therapy), By Product (Cyclotrons, Synchrotons, Synchrocyclotrons), By Cancer Type (Paediatric Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, Others) and Regional Forecast, 2020-2027

Region : Global | Report ID: FBI103352 | Status : Ongoing

 

KEY MARKET INSIGHTS

According to the American Cancer Society 2020 Facts & Figures, in 2020 more than 1.8 million new cancer cases are likely to be diagnosed. Such increasing prevalence of the lethal disorder is demanding for advanced treatment therapies. Particle therapy is one of the advanced therapy used against cancer treatment. The external beam radiotherapy uses proton, neutrons for treatment of the tumor. Due to release of the energetic ionizing particles at the target site, it damages the DNA of the cells thus causing death of the tumor cells. Therefore, this radiation therapy is likely to create opportunities during the forecast period eventually increasing its market potential. Moreover, setup of particle therapy systems in the hospitals to deliver advanced treatment therapies to the cancer patients is anticipated to drive the market growth in the near future.


The major factor driving the global particle therapy market is the growing need for development of advanced therapies effective against cancer treatment. Moreover, increasing prevalence of cancer, rising number of particle therapy centre is also likely to contribute to the growth of the global market.


On the flip side, higher cost of the test undertaken coupled with lack of insurance coverage policies for particle therapy is expected to restrain the market growth. Additionally, infrastructural challenges are also likely to hinder the market growth.


Key Market Driver -

Need for advanced therapies in cancer treatment

Key Market Restraint -

Availability of limited insurance coverage for particle therapy


Market Segmentation:


By type, the market is segmented into proton therapy and heavy ion therapy. Based on product, the market is segmented into cyclotrons, synchrotrons, and synchrocyclotrons. Based on cancer type, the particle therapy market is segmented into paediatric cancer, prostate cancer, lung cancer, breast cancer, and others.


From a geographical standpoint, the market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.


Key Players Covered:


The major companies in the global particle therapy market report includes Varian Medical Systems, Inc., Mevion Medical Systems, Inc., Provision Healthcare, LLC, Ion Beam Applications SA, Sumitomo Heavy Industries, Ltd., Optivus Proton Therapy, Inc., ProTom International, Inc., Advanced Oncotherapy plc, and others.


Key Insights



  • Advancements in the Particle Therapy

  • New Product Launch

  • Regulatory Scenario

  • Prevalence of Cancer – By Key Countries/Regions

  • Key Industry Developments – Mergers, Acquisitions, and Partnerships


Regional Analysis:


To gain extensive insights into the market, Request for Customization


The global particle therapy market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America followed by Europe dominated the global particle therapy market in 2019, owing to the rise in R&D of the pharmaceutical & biotechnology industries. However, increasing patient pool suffering from cancer and demand for advanced treatment therapies in Asia Pacific is likely to accelerate the growth of the market. This coupled with growing mergers and acquisitions between industry players and improving healthcare infrastructure is likely to promote the adoption of particle therapy in countries like China, India, and other countries. Latin America and Middle East & Africa are projected to register a comparatively lower CAGR by the end of the forecast period.


Segmentation


























 ATTRIBUTE


  DETAILS

By Type




  • Proton Therapy

  • Heavy Ion Therapy



By Product




  • Cyclotrons

  • Synchrotons

  • Synchrocyclotrons



By Cancer Type




  • Paediatric Cancer

  • Prostate Cancer

  • Lung Cancer

  • Breast Cancer

  • Others



By Geography




  • North America (USA, Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, Rest of Latin America)

  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)



Particle Therapy Industry Developments



  • In May 2020, Hitachi Ltd announced the setup of advanced proton therapy system in Clinica Universidad de Navarra in Spain. The system includes spot scanning technology that sends proton beam to the target tumor.

  • In September 2019, IBA announced the launch of development of cyclotron based carbon therapy in Caen, France. This is world’s first carbon system effective against cancer treatment.


Particle Therapy Market Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2019
  • 2016-2018

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization

Healthcare Clients

SUANFARMA
Abbott
lpsos
baxter
Intuitive_Surgical_logo

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X